Literature DB >> 15507304

Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages.

P L Delputte1, P Meerts, S Costers, H J Nauwynck.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) induces respiratory distress in young pigs and reproductive failure in sows. In PRRSV infected pigs, virus persists for several weeks to several months. Although IPMA antibodies are detected from 7 days post inoculation (pi), virus neutralizing (VN) antibodies are commonly detected starting from 3 weeks pi with an SN test on Marc-145 cells. Since infection of Marc-145 cells is quite different compared to infection of macrophages, the in vivo target cell, the role of these VN antibodies in in vivo protection is questionable. In our study, we demonstrated that antibodies from pigs early in infection with PRRSV Lelystad virus (14 days pi) showed no neutralization in the SN test on Marc-145 cells, but partially reduced Lelystad virus infection of porcine alveolar macrophages. At 72 days pi, VN antibodies were detected by the SN test on Marc-145 cells, and these protected macrophages completely against Lelystad virus infection. In contrast, these VN antibodies only partially reduced porcine alveolar macrophage infection of a Belgian PRRSV isolate (homologous virus), and had no effect on infection of porcine alveolar macrophages with the American type VR-2332 strain (heterologous virus). Confocal analysis of Lelystad virus attachment and internalization in macrophages showed that antibodies blocked infection through both a reduction in virus attachment, and a reduction of PRRSV internalization. Western immunoblotting analysis revealed that sera from 14 days pi, which showed no neutralization in the SN test on Marc-145 cells but partially reduced Lelystad virus infection of macrophages, predominantly recognized the Lelystad virus N protein, and reacted faintly with the M envelope protein. Sera from 72 days pi, with VN antibodies that blocked infection of Marc-145 cells and PAM, reacted with the N protein and the two major envelope proteins M and GP5. Using the Belgian PRRSV isolate 94V360 an identical but less intense reactivity profile was obtained. VN sera also recognized the VR-2332 N and M protein, but not the GP5 protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507304     DOI: 10.1016/j.vetimm.2004.09.007

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  17 in total

1.  Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge.

Authors:  Sally R Robinson; Michael C Rahe; Diem K Gray; Kyra V Martins; Michael P Murtaugh
Journal:  Virus Res       Date:  2018-02-03       Impact factor: 3.303

2.  Inhibition of porcine reproductive and respiratory syndrome virus replication by RNA interference in MARC-145 cells.

Authors:  Yonghua Bao; Yongchen Guo; Liying Zhang; Zhihui Zhao; Ning Li
Journal:  Mol Biol Rep       Date:  2011-06-12       Impact factor: 2.316

3.  Efficacy of an inactivated PRRSV vaccine: induction of virus-neutralizing antibodies and partial virological protection upon challenge.

Authors:  Gerald Misinzo; Peter L Delputte; Peter Meerts; Christa Drexler; Hans J Nauwynck
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

4.  A variable region in GP4 of European-type porcine reproductive and respiratory syndrome virus induces neutralizing antibodies against homologous but not heterologous virus strains.

Authors:  Merijn Vanhee; Sarah Costers; Wander Van Breedam; Marc F Geldhof; Jan Van Doorsselaere; Hans J Nauwynck
Journal:  Viral Immunol       Date:  2010-08       Impact factor: 2.257

5.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

6.  An intact sialoadhesin (Sn/SIGLEC1/CD169) is not required for attachment/internalization of the porcine reproductive and respiratory syndrome virus.

Authors:  Randall S Prather; Raymond R R Rowland; Catherine Ewen; Benjamin Trible; Maureen Kerrigan; Bhupinder Bawa; Jennifer M Teson; Jiude Mao; Kiho Lee; Melissa S Samuel; Kristin M Whitworth; Clifton N Murphy; Tina Egen; Jonathan A Green
Journal:  J Virol       Date:  2013-06-19       Impact factor: 5.103

7.  Interaction of the European genotype porcine reproductive and respiratory syndrome virus (PRRSV) with sialoadhesin (CD169/Siglec-1) inhibits alveolar macrophage phagocytosis.

Authors:  Miet I De Baere; Hanne Van Gorp; Peter L Delputte; Hans J Nauwynck
Journal:  Vet Res       Date:  2012-05-25       Impact factor: 3.683

8.  Susceptible cell lines for the production of porcine reproductive and respiratory syndrome virus by stable transfection of sialoadhesin and CD163.

Authors:  Iris Delrue; Hanne Van Gorp; Jan Van Doorsselaere; Peter L Delputte; Hans J Nauwynck
Journal:  BMC Biotechnol       Date:  2010-06-29       Impact factor: 2.563

9.  Inhibition of highly pathogenic PRRSV replication in MARC-145 cells by artificial microRNAs.

Authors:  Shuqi Xiao; Qiwei Wang; Jintao Gao; Liangliang Wang; Zuyong He; Delin Mo; Xiaohong Liu; Yaosheng Chen
Journal:  Virol J       Date:  2011-11-01       Impact factor: 4.099

10.  The M/GP(5) glycoprotein complex of porcine reproductive and respiratory syndrome virus binds the sialoadhesin receptor in a sialic acid-dependent manner.

Authors:  Wander Van Breedam; Hanne Van Gorp; Jiquan Q Zhang; Paul R Crocker; Peter L Delputte; Hans J Nauwynck
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.